Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

First Tracks Biotherapeutics, Inc.

NASDAQ: TRAX · Life Sciences · 5 alerts · CIK 2091349

First Tracks Biotherapeutics, Inc. stories on ALFA USA NewsRead the news →
Share price
$46.56Close, Nov 16
Market cap
$1.96B
Shares outstanding
42.02MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All First Tracks Biotherapeutics, Inc. filings on SEC EDGAR ↗

8:33 AM ET 8-K
Clinical Trial Data

First Tracks Biotherapeutics Clinical Trial Data

First Tracks Biotherapeutics announced positive topline data from the first Phase 1b cohort of its drug candidate ANB033 for the treatment of Celiac Disease. The company also updated its corporate investor presentation to reflect these clinical developments.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.